IBD | VCIT | IBD / VCIT | |
Gain YTD | 4.533 | 5.098 | 89% |
Net Assets | 389M | 55.2B | 1% |
Total Expense Ratio | 0.43 | 0.03 | 1,433% |
Turnover | 26.00 | 72.00 | 36% |
Yield | 4.26 | 4.44 | 96% |
Fund Existence | 8 years | 16 years | - |
IBD | VCIT | |
---|---|---|
RSI ODDS (%) | N/A | 4 days ago47% |
Stochastic ODDS (%) | 4 days ago53% | 4 days ago52% |
Momentum ODDS (%) | 4 days ago63% | N/A |
MACD ODDS (%) | 4 days ago66% | N/A |
TrendWeek ODDS (%) | 4 days ago67% | 4 days ago52% |
TrendMonth ODDS (%) | 4 days ago68% | 4 days ago53% |
Advances ODDS (%) | 20 days ago62% | 17 days ago51% |
Declines ODDS (%) | N/A | 4 days ago50% |
BollingerBands ODDS (%) | 4 days ago60% | 4 days ago46% |
Aroon ODDS (%) | 4 days ago70% | 4 days ago56% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYTNX | 350.32 | 5.63 | +1.63% |
Rydex S&P 500 2x Strategy H | |||
ACAYX | 52.35 | 0.63 | +1.22% |
Alger Capital Appreciation Instl Y | |||
WFEMX | 17.28 | 0.14 | +0.82% |
WCM Focused Emerging Markets Investor | |||
PEMCX | 13.17 | 0.08 | +0.61% |
Principal Edge MidCap A | |||
TRIGX | 21.54 | 0.03 | +0.14% |
T. Rowe Price International Value Eq |